Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine

A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases 2022-04, Vol.28 (4), p.870-872
Main Authors: Miyazato, Yusuke, Yamamoto, Kei, Yamada, Gen, Kubota, Shuji, Ishikane, Masahiro, Sugiyama, Masaya, Ueno, Mikako, Matsunaga, Akihiro, Miyoshi-Akiyama, Tohru, Ishizaka, Yukihito, Ohmagari, Norio
Format: Article
Language:English
Subjects:
Adult
coronavirus disease
Coronaviruses
COVID-19
COVID-19 - prevention & control
COVID-19 vaccines
COVID-19 Vaccines - adverse effects
Disease control
Disease prevention
Disease transmission
Drug dosages
Dyspnea
Edema
Fever
Humans
Immunization
Infections
Infectious diseases
Male
Medical laboratories
Medical research
Medicine
mRNA Vaccines
Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine
Multisystem inflammatory syndrome in children
Myocarditis
Patients
R&D
Research & development
Research Letter
respiratory failure
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Steroids
vaccination
Vaccines, Synthetic
Ventilation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem inflammatory syndrome. COVID-19 vaccination could be a trigger for this condition.
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2804.212585